Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy (Q39192905)

9 September 2017

title

Asthma management: A new phenotype-based approach using presence of eosinophilia and allergy (English)

1 reference

9 September 2017

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

P Cap

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

R Dvořáková

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

V Kašák

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

T Kočí

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

B Novotna

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

E Seberova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

V Zindr

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

22 March 2017

1 reference

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1279-1287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

EAACI position statement on asthma exacerbations and severe asthma

2 June 2020

cites work

1 reference

Severe asthma: advances in current management and future therapy

21 January 2018

1 reference

Current treatment of severe asthma

21 January 2018

1 reference

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

21 January 2018

1 reference

Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial

21 January 2018

1 reference

Severe asthma with fungal sensitization

21 January 2018

1 reference

Allergic fungal airway disease: pathophysiologic and diagnostic considerations

21 January 2018

1 reference

Severe asthma: from characteristics to phenotypes to endotypes

21 January 2018

1 reference

The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

21 January 2018

1 reference

Direct and indirect challenges in the clinical assessment of asthma

21 January 2018

1 reference

Direct challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance

21 January 2018

1 reference

Markers of eosinophilic inflammation and tissue re-modelling in children before clinically diagnosed bronchial asthma

21 January 2018

1 reference

21 January 2018

1 reference

Asthma: defining of the persistent adult phenotypes

21 January 2018

1 reference

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

A large subgroup of mild-to-moderate asthma is persistently noneosinophilic

21 January 2018

1 reference

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

21 January 2018

1 reference

A new perspective on concepts of asthma severity and control.

21 January 2018

1 reference

Cluster analysis and clinical asthma phenotypes.

21 January 2018

1 reference

Clinical phenotypes of asthma

21 January 2018

1 reference

Interpretative strategies for lung function tests

21 January 2018

1 reference

Eosinophils, bronchitis and asthma: pathogenesis of cough and airflow obstruction.

21 January 2018

1 reference

"Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids

21 January 2018

1 reference

A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).

21 January 2018

1 reference

Exhaled nitric oxide: a predictor of steroid response

21 January 2018

1 reference

Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis

21 January 2018

1 reference

Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma

21 January 2018

1 reference

An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications

21 January 2018

1 reference

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

21 January 2018

1 reference

Inflammatory mechanisms and remodeling in chronic rhinosinusitis and nasal polyps

21 January 2018

1 reference

Phenotyping airways disease: an A to E approach.

21 January 2018

1 reference

The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease

21 January 2018

1 reference

Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide

21 January 2018

1 reference

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

21 January 2018

1 reference

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

21 January 2018

1 reference

Current control and future risk in asthma management

21 January 2018

1 reference

Approaches to stepping up and stepping down care in asthmatic patients

21 January 2018

1 reference

Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study

21 January 2018

1 reference

The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations

21 January 2018

1 reference

Aeroallergen sensitization in asthma: prevalence and correlation with severity

21 January 2018

1 reference

The link between fungi and severe asthma: a summary of the evidence.

21 January 2018

1 reference

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*

21 January 2018

1 reference

Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment

21 January 2018

1 reference

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

Allergen immunotherapy: A practice parameter third update

21 January 2018

1 reference

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Asso

21 January 2018

1 reference

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

21 January 2018

1 reference

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

21 January 2018

1 reference

Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs

21 January 2018

1 reference

An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.13165

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28328094%20AND%20SRC:MED&resulttype=core&format=json